Comparator: M-M-R II

BIOLOGICAL5 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

MeaslesMumpsRubellaVaricella

Phase 2

ProQuad Dose Selection Study (V221-011)(COMPLETED)

CompletedNCT00986232

Merck Sharp & Dohme LLCMeasles, Mumps, Rubella +1

Start: 1999-04-30End: 2000-09-30Updated: 2015-04-10

Phase 3

ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)

CompletedNCT00975507

Merck Sharp & Dohme LLCMeasles, Mumps, Rubella +1

Start: 1998-03-31End: 1999-06-30Updated: 2015-10-06

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

CompletedNCT00984295

Merck Sharp & Dohme LLCMeasles, Mumps, Rubella +1

Start: 2000-06-30End: 2001-12-31Updated: 2015-08-07

A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

CompletedNCT00985166

Merck Sharp & Dohme LLCMeasles, Mumps, Rubella +1

Start: 2000-08-31End: 2003-05-31Updated: 2015-07-28

Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)

CompletedNCT00985153

Merck Sharp & Dohme LLCMeasles, Mumps, Rubella +1

Start: 2000-03-31End: 2001-05-31Updated: 2015-11-23